REPORTS

Let’s Pullulate and Expand Your Business

Global Recombinant Human Granulocyte Colony-Stimulating Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 14, 2020  |  211 PAGES  |  REPORT CODE: CMM367091
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Recombinant Human Granulocyte Colony-Stimulating is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The research provides insights for the global Recombinant Human Granulocyte Colony-Stimulating market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Recombinant Human Granulocyte Colony-Stimulating industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Recombinant Human Granulocyte Colony-Stimulating Market Segmentations:

By Players:

  • Amgen

  • Huaxin

  • Kyowa Hakko Kirin

  • Qilu Pharmaceutical

  • Hangzhou Jiuyuan

  • Shijiazhuang Pharmaceutical

  • Sinovac

  • Amoytop Biotech

  • Gensci

  • Triprime

  • Zhaoke

  • Kawin

By Types:

  • Lenograstim (Granocyte)

  • Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

  • Others

By End-User:

  • Chemotherapy Induced Neutropenia

  • Before Blood Donation

  • Stem Cell Transplants

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Human Granulocyte Colony-Stimulating Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Lenograstim (Granocyte) from 2014 to 2026

    • 1.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) from 2014 to 2026

    • 1.3.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Chemotherapy Induced Neutropenia from 2014 to 2026

    • 1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Before Blood Donation from 2014 to 2026

    • 1.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Stem Cell Transplants from 2014 to 2026

    • 1.4.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Recombinant Human Granulocyte Colony-Stimulating Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Recombinant Human Granulocyte Colony-Stimulating by Major Types

    • 3.4.1 Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Lenograstim (Granocyte)

    • 3.4.2 Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

    • 3.4.3 Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others

4 Segmentation of Recombinant Human Granulocyte Colony-Stimulating Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Recombinant Human Granulocyte Colony-Stimulating by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Recombinant Human Granulocyte Colony-Stimulating in Chemotherapy Induced Neutropenia

    • 4.4.2 Market Size and Growth Rate of Recombinant Human Granulocyte Colony-Stimulating in Before Blood Donation

    • 4.4.3 Market Size and Growth Rate of Recombinant Human Granulocyte Colony-Stimulating in Stem Cell Transplants

    • 4.4.4 Market Size and Growth Rate of Recombinant Human Granulocyte Colony-Stimulating in Others

5 Market Analysis by Major Regions

  • 5.1 Global Recombinant Human Granulocyte Colony-Stimulating Production Analysis by Major Regions

  • 5.2 Global Recombinant Human Granulocyte Colony-Stimulating Consumption Analysis by Major Regions

  • 5.3 Global Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis

6 Product Commodity of Recombinant Human Granulocyte Colony-Stimulating Market in Major Countries

  • 6.1 Top 5 Export Countries in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis

  • 7.1 North America Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Types

  • 7.2 North America Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major End-Users

  • 7.3 North America Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Countries

    • 7.3.1 United States Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 7.3.2 Canada Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 7.3.3 Mexico Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

8 Europe Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis

  • 8.1 Europe Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Types

  • 8.2 Europe Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major End-Users

  • 8.3 Europe Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Countries

    • 8.3.1 Germany Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.2 UK Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.3 France Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.4 Italy Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.6 Spain Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.7 Belgium Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.8 Poland Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.9 Russia Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 8.3.10 Turkey Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

9 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis

  • 9.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Types

  • 9.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Countries

    • 9.3.1 China Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 9.3.2 Japan Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 9.3.4 India Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 9.3.6 South Korea Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

10 Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 10.3.2 Brazil Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 10.3.3 Nigeria Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

    • 10.3.4 South Africa Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate 

    • 10.3.5 Argentina Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Amgen

    • 11.1.1 Amgen Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Huaxin

    • 11.2.1 Huaxin Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Kyowa Hakko Kirin

    • 11.3.1 Kyowa Hakko Kirin Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Qilu Pharmaceutical

    • 11.4.1 Qilu Pharmaceutical Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Hangzhou Jiuyuan

    • 11.5.1 Hangzhou Jiuyuan Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Shijiazhuang Pharmaceutical

    • 11.6.1 Shijiazhuang Pharmaceutical Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Sinovac

    • 11.7.1 Sinovac Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Amoytop Biotech

    • 11.8.1 Amoytop Biotech Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Gensci

    • 11.9.1 Gensci Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Triprime

    • 11.10.1 Triprime Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Zhaoke

    • 11.11.1 Zhaoke Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Kawin

    • 11.12.1 Kawin Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 97 Figures and 143 Tables)

  • Figure Product Picture

  • Figure Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Lenograstim (Granocyte) from 2014 to 2026

  • Figure Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) from 2014 to 2026

  • Figure Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Chemotherapy Induced Neutropenia from 2014 to 2026

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Before Blood Donation from 2014 to 2026

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Stem Cell Transplants from 2014 to 2026

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Recombinant Human Granulocyte Colony-Stimulating Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Recombinant Human Granulocyte Colony-Stimulating

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Recombinant Human Granulocyte Colony-Stimulating by Different Types from 2014 to 2026

  • Table Consumption Share of Recombinant Human Granulocyte Colony-Stimulating by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Lenograstim (Granocyte)

  • Figure Market Size and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Recombinant Human Granulocyte Colony-Stimulating by Different End-Users from 2014 to 2026

  • Table Consumption Share of Recombinant Human Granulocyte Colony-Stimulating by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Chemotherapy Induced Neutropenia

  • Figure Market Size and Growth Rate of Before Blood Donation

  • Figure Market Size and Growth Rate of Stem Cell Transplants

  • Figure Market Size and Growth Rate of Others

  • Table Global Recombinant Human Granulocyte Colony-Stimulating Production by Major Regions

  • Table Global Recombinant Human Granulocyte Colony-Stimulating Production Share by Major Regions

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Production Share by Major Regions in 2014

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Production Share by Major Regions in 2018

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Production Share by Major Regions in 2026

  • Table Global Recombinant Human Granulocyte Colony-Stimulating Consumption by Major Regions

  • Table Global Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Regions

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Regions in 2014

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Regions in 2018

  • Figure Global Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Regions in 2026

  • Table North America Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis

  • Table Europe Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Recombinant Human Granulocyte Colony-Stimulating market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Recombinant Human Granulocyte Colony-Stimulating Consumption by Types from 2014 to 2026

  • Table North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types from 2014 to 2026

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2014

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2018

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2026

  • Table North America Recombinant Human Granulocyte Colony-Stimulating Consumption by End-Users from 2014 to 2026

  • Table North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users from 2014 to 2026

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2014

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2018

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2026

  • Table North America Recombinant Human Granulocyte Colony-Stimulating Consumption by Major Countries from 2014 to 2026

  • Table North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2014

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2018

  • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2026

  • Figure United States Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption by Types from 2014 to 2026

  • Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types from 2014 to 2026

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2014

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2018

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2026

  • Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption by End-Users from 2014 to 2026

  • Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2014

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2018

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2026

  • Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption by Major Countries from 2014 to 2026

  • Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2014

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2018

  • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2026

  • Figure Germany Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure France Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption by Types from 2014 to 2026

  • Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2014

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2018

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2026

  • Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2014

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2018

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2026

  • Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2026

  • Figure China Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandRecombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure India Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Share by Major Countries in 2026

  • Figure GCC Countries Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Recombinant Human Granulocyte Colony-Stimulating Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Amgen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

  • Figure Sales and Growth Rate Analysis of Amgen

  • Figure Revenue and Market Share Analysis of Amgen

  • Table Product and Service Introduction of Amgen

  • Table Company Profile and Development Status of Huaxin

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Huaxin

  • Figure Sales and Growth Rate Analysis of Huaxin

  • Figure Revenue and Market Share Analysis of Huaxin

  • Table Product and Service Introduction of Huaxin

  • Table Company Profile and Development Status of Kyowa Hakko Kirin

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kyowa Hakko Kirin

  • Figure Sales and Growth Rate Analysis of Kyowa Hakko Kirin

  • Figure Revenue and Market Share Analysis of Kyowa Hakko Kirin

  • Table Product and Service Introduction of Kyowa Hakko Kirin

  • Table Company Profile and Development Status of Qilu Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qilu Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Qilu Pharmaceutical

  • Figure Revenue and Market Share Analysis of Qilu Pharmaceutical

  • Table Product and Service Introduction of Qilu Pharmaceutical

  • Table Company Profile and Development Status of Hangzhou Jiuyuan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hangzhou Jiuyuan

  • Figure Sales and Growth Rate Analysis of Hangzhou Jiuyuan

  • Figure Revenue and Market Share Analysis of Hangzhou Jiuyuan

  • Table Product and Service Introduction of Hangzhou Jiuyuan

  • Table Company Profile and Development Status of Shijiazhuang Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shijiazhuang Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Shijiazhuang Pharmaceutical

  • Figure Revenue and Market Share Analysis of Shijiazhuang Pharmaceutical

  • Table Product and Service Introduction of Shijiazhuang Pharmaceutical

  • Table Company Profile and Development Status of Sinovac

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinovac

  • Figure Sales and Growth Rate Analysis of Sinovac

  • Figure Revenue and Market Share Analysis of Sinovac

  • Table Product and Service Introduction of Sinovac

  • Table Company Profile and Development Status of Amoytop Biotech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amoytop Biotech

  • Figure Sales and Growth Rate Analysis of Amoytop Biotech

  • Figure Revenue and Market Share Analysis of Amoytop Biotech

  • Table Product and Service Introduction of Amoytop Biotech

  • Table Company Profile and Development Status of Gensci

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gensci

  • Figure Sales and Growth Rate Analysis of Gensci

  • Figure Revenue and Market Share Analysis of Gensci

  • Table Product and Service Introduction of Gensci

  • Table Company Profile and Development Status of Triprime

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triprime

  • Figure Sales and Growth Rate Analysis of Triprime

  • Figure Revenue and Market Share Analysis of Triprime

  • Table Product and Service Introduction of Triprime

  • Table Company Profile and Development Status of Zhaoke

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhaoke

  • Figure Sales and Growth Rate Analysis of Zhaoke

  • Figure Revenue and Market Share Analysis of Zhaoke

  • Table Product and Service Introduction of Zhaoke

  • Table Company Profile and Development Status of Kawin

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kawin

  • Figure Sales and Growth Rate Analysis of Kawin

  • Figure Revenue and Market Share Analysis of Kawin

  • Table Product and Service Introduction of Kawin


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top